Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Comparable antitumor effects of SEF-19 and CGS-20267 in rat breast cancer model

May 21, 1998

Targeted Genetics' E1A gene therapy headed for phase II trials in head and neck cancer

May 20, 1998

T-cell gene therapy developed at Cell Genesys markedly reduces TAG-72 blood levels

May 20, 1998

Preliminary clinical results indicate good tolerability for LGD-1550 in cancer patients

May 20, 1998

Promising phase I/II findings in NSCLC reported for INGN-201 at ASCO

May 20, 1998

Pharmacokinetics of capecitabine affected by food

May 20, 1998

C225 + radiotherapy produces 100% response rate in head and neck cancer

May 19, 1998

Cytokine suppressants: an effective approach to the treatment of cancer cachexia

May 19, 1998

Phase I toxicity and efficacy results for CT-2584 presented at ASCO meeting

May 19, 1998

Matrix proceeds with full enrollment for IntraDose phase II trials

May 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...